Snap-8: research, legal status and who sells it
This page is information, not medical advice. Snap-8 is not approved as a medicine in the markets below unless stated. We don't publish dosing or usage instructions.
- Also known as
- Acetyl octapeptide-3, SNAP-8
- Category
- Synthetic octapeptide (acetyl octapeptide-3) used in anti-wrinkle cosmetics
- Evidence level
- Preclinical (lab and animal studies)
- Price range
- $0.900/mg to $5.50/mg, median $3.05/mg across 33 vendors (compare)
- Our lab tests
- None yet (how testing will work)
Legal and regulatory status
| Where | Status |
|---|---|
| United States | No FDA-approved drug contains Snap-8 (acetyl octapeptide-3) [1]. |
| United Kingdom | No UK-licensed medicine containing Snap-8 appears in the MHRA products database [2]. |
| European Union | No medicine containing Snap-8 (acetyl octapeptide-3) is authorized in the EU, according to EMA's central and Article 57 product data [3][4]. |
| Canada | No product containing Snap-8 (acetyl octapeptide-3) appears in Health Canada's Drug Product Database [5]. |
| Australia | Snap-8 (acetyl octapeptide-3) is not named in Australia's Poisons Standard (October 2026) [6]. |
| Sport (WADA) | Not named on the 2026 Prohibited List [7]. |
We haven't published a full overview of Snap-8 yet. The legal status table and live prices on this page are current.
Snap-8 prices: cheapest listings
The five lowest $/mg listings out of 41. See all Snap-8 prices
| Vendor | Transparency | Product | Size | Price | $/mg | Stock | Vendor's page |
|---|---|---|---|---|---|---|---|
| Bulk Peptide Wholesale | 45 | 10 mg × 10 | $90 | $0.900/mg | View | ||
| Nationwide Peptides | 85 | 100 mg | $90 | $0.900/mg | View | ||
| Nexaph | 45 | 20 mg × 10 | $198 | $0.990/mg | View | ||
| Iron Aminos | 40 | 10 mg × 10 | $170 | $1.70/mg | View | ||
| Licensed Peptides | 62 | 10 mg × 10 | $171 | $1.71/mg | Out of stock | View |
Sources
- Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 15, 2026
- MHRA Products: licensed-medicine search for "snap-8". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 15, 2026
- EMA medicines data: centrally authorised human medicines (export of 14 October 2026). European Medicines Agency. Accessed Oct 15, 2026
- EMA Article 57 product data: medicines authorised in the EU/EEA (data as of 9 October 2026). European Medicines Agency. Accessed Oct 15, 2026
- Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 15, 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 15, 2026
- World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 15, 2026
- Current Approaches in Cosmeceuticals: Peptides, Biotics and Marine Biopolymers. Polymers (2025). Accessed Oct 15, 2026
- Peptides: Emerging Candidates for the Prevention and Treatment of Skin Senescence: A Review. Biomolecules (2025). Accessed Oct 15, 2026